معرفی
Katrina Pollock is an Honorary Clinical Senior Lecturer and Senior Clinical Research Fellow in the Department of Infectious Disease at Imperial College London. She is affiliated with the Faculty of Medicine and works closely with Imperial College Healthcare NHS Trust. Her research focuses on vaccinology, particularly investigating T cell responses to accelerate vaccine design for pathogens like HIV, chlamydia, and SARS-CoV-2. She leads first-in-human trials and experimental medicine studies, including the Imperial College London self-amplifying RNA SARS-CoV-2 vaccine trial and the Oxford AstraZeneca COVID-19 vaccine trial.
Pollock holds a medical degree from Newnham College, University of Cambridge, and Imperial College London, followed by specialty training in genitourinary medicine and immunology. Her work bridges clinical practice and research, addressing public health challenges through immunological innovation.
- Education:
- MBBS, Newnham College, University of Cambridge
- Medical Training, Imperial College London
- Specialty training in genitourinary medicine and immunology
Her research interests span clinical sciences, medical microbiology, and immunology, with a focus on vaccine development and immune response mechanisms. She has contributed to pivotal studies on influenza, HIV, and SARS-CoV-2 vaccines, emphasizing the role of lymph nodes in antibody production and T cell dynamics.
Pollock received the Department of Infectious Disease Award for exceptional contributions during the COVID-19 pandemic. Her work on vaccine booster responses in immunosuppressed populations has advanced understanding of variant-specific immunity.
She leads major clinical trials and collaborates with global networks such as the Vaccine Research Network. Her grants and studies address vaccine efficacy in diverse populations, including those with inflammatory bowel disease and HIV. Pollock’s lab focuses on experimental medicine and translational vaccinology, leveraging cutting-edge immunological techniques.
